Mulay James
Director at CGON
- Sold, on record
- $6.3M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Jul 10, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CGONCG Oncology, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CGONRoutineOct 9, 2025 2025
Sold 5,903 shares at $43.99 ($260k)
Mulay James, Director
10b5-1 planSold 100% of holdings ($260k position)0 shares left0.3x usual sizeFollows a Form 144Filing
- 2 Form 144 notice CGONNoticeJan 9, 2026 +92 days
Filed to sell 13,109 shares ($550k)
Mulay James, Director
10b5-1 plan0.7x usual sizeFiling
- 3 Form 4 sale CGONRoutineJan 9, 2026 same day
Sold 11,145 shares at $52.47 ($585k)
Mulay James, Director
10b5-1 planSold 100% of holdings ($585k position)0 shares left0.6x usual sizeFollows a Form 144Filing
- 4 Form 4 sale CGONRoutineMar 16, 2026 +66 days
Sold 1,964 shares at $63.50 ($125k)
Mulay James, Director
10b5-1 planSold 100% of holdings ($125k position)0 shares left0.2x usual sizeFollows a Form 144Filing
- 5 Form 144 notice CGONNoticeApr 17, 2026 +32 days
Filed to sell 17,564 shares ($1.2M)
Mulay James, Director
10b5-1 plan1.5x usual sizeFiling
- 6 Form 4 sale CGONRoutineApr 17, 2026 same day
Sold 15,600 shares at $73.01 ($1.1M)
Mulay James, Director
10b5-1 planSold 100% of holdings ($1.1M position)0 shares left1.3x usual sizeFollows a Form 144Filing
- 7 Form 4 sale CGONRoutineJun 15, 2026 +59 days
Sold 1,964 shares at $60.12 ($118k)
Mulay James, Director
10b5-1 planSold 100% of holdings ($118k position)0 shares left0.2x usual sizeFiling
- 8 Form 4 sale CGONRoutineJul 10, 2026 +25 days
Sold 24,165 shares at $75.16 ($1.8M)
Mulay James, Director
10b5-1 planSold 100% of holdings ($1.8M position)0 shares left2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 14, 2026 | CGON | Director | Form 4 sale | 24,165 | $1.8M | 100.0% | Routine | SEC |
| Jun 15, 2026 | Jun 16, 2026 | CGON | Director | Form 4 sale | 1,964 | $118k | 100.0% | Routine | SEC |
| Apr 17, 2026 | Apr 20, 2026 | CGON | Director | Form 4 sale | 15,600 | $1.1M | 100.0% | Routine | SEC |
| Apr 17, 2026 | Apr 17, 2026 | CGON | Director | Form 144 notice | 17,564 | $1.2M | Notice | SEC | |
| Mar 16, 2026 | Mar 17, 2026 | CGON | Director | Form 4 sale | 1,964 | $125k | 100.0% | Routine | SEC |
| Jan 9, 2026 | Jan 13, 2026 | CGON | Director | Form 4 sale | 11,145 | $585k | 100.0% | Routine | SEC |
| Jan 9, 2026 | Jan 9, 2026 | CGON | Director | Form 144 notice | 13,109 | $550k | Notice | SEC | |
| Oct 9, 2025 | Oct 10, 2025 | CGON | Director | Form 4 sale | 5,903 | $260k | 100.0% | Routine | SEC |
| Oct 9, 2025 | Oct 9, 2025 | CGON | Director | Form 144 notice | 6,557 | $267k | Notice | SEC | |
| Sep 29, 2025 | Sep 30, 2025 | CGON | Director | Form 4 sale | 12,755 | $500k | 100.0% | Routine | SEC |
| Sep 19, 2025 | Sep 22, 2025 | CGON | Director | Form 4 sale | 22,686 | $885k | 100.0% | Routine | SEC |
| Sep 18, 2025 | Sep 18, 2025 | CGON | Director | Form 144 notice | 35,441 | $1.3M | Notice | SEC | |
| Sep 5, 2025 | Sep 8, 2025 | CGON | Director | Form 4 sale | 27,015 | $852k | 100.0% | Routine | SEC |
| Sep 5, 2025 | Sep 5, 2025 | CGON | Director | Form 144 notice | 27,015 | $836k | Notice | SEC |